by John R. Fischer
, Senior Reporter | November 01, 2018
In addition, researchers have or plan to test their approach in trials for liver and prostate cancers, as well as for conditions outside of cancer, such as breast density, as a risk factor, and the density of muscles to quantify age-related muscle loss.
However, the solution still requires more testing on newer forms of technology before consideration for the market can take place.
Carestream Health is a leading provider of quality X-ray systems and detectors that are designed to maximize diagnostic confidence, workflow and patient satisfaction. Follow the link above to see our complete portfolio of digital radiography solutions.
“Commercially, such data is available in the newest generation of ultrasound machines. Still, for us to be able to integrate our software solution we would need close collaboration with the manufacturer, as these systems typically are not open for access externally, due to understandable safety and certification concerns. We are currently exploring our options with such collaborations to be able to bring our technology to market as soon as possible.”
The team currently utilizes research machines with the hopes of developing a system that works with the push of a button, an endeavor supported by a grant from Innosuisse.
The technology was developed with the support of the Swiss National Science Foundation.
The findings of their most recent work were published in the journal, Physics in Medicine and Biology
. Back to HCB News